Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase–Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies( )

In the CREDIBLE-CR and APEKS-NP studies, cefiderocol treatment was effective against gram-negative bacteria producing metallo-B-lactamases; rates of clinical cure (70.8% [17/24]), microbiological eradication (58.3% [14/24]), and day 28 all-cause mortality (12.5% [3/24]) compared favorably with compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Timsit, Jean Francois, Paul, Mical, Shields, Ryan K, Echols, Roger, Baba, Takamichi, Yamano, Yoshinori, Portsmouth, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522395/
https://www.ncbi.nlm.nih.gov/pubmed/35148378
http://dx.doi.org/10.1093/cid/ciac078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522395/
https://www.ncbi.nlm.nih.gov/pubmed/35148378
http://dx.doi.org/10.1093/cid/ciac078

Ejemplares similares